adam10 polyclonal antibody Search Results


anti adam10 antibody  (Bioss)
92
Bioss anti adam10 antibody
Anti Adam10 Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti adam10 antibody/product/Bioss
Average 92 stars, based on 1 article reviews
anti adam10 antibody - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier
rabbit anti adam10  (OriGene)
92
OriGene rabbit anti adam10
Rabbit Anti Adam10, supplied by OriGene, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti adam10/product/OriGene
Average 92 stars, based on 1 article reviews
rabbit anti adam10 - by Bioz Stars, 2026-05
92/100 stars
  Buy from Supplier
anti adam10  (OriGene)
88
OriGene anti adam10
<t>ADAM10</t> and ADAM17 in APP processing of breast cancer cell lines. (A) Immunoblot analysis using antibodies against ADAM10 and ADAM17 showed the expression of both proteins in breast cancer cell lines (BT-549, MDA-MB231, MCF7, MDA-MB468, SK-BR-3 and ZR-75-1). β-actin was used as a control. Densitometric analysis of protein expression on the predominant form detected (pro-ADAM17 and mature ADAM10) from replicate experiments were shown at the lower panel. (mean ± SD; n = 3). (B) Knockdown of ADAM 10 but not ADAM17 showed reduced sAPP level in conditioned medium from cell line culture. Breast cancer cell line (MDA-MB231) was transfected with ADAM10 or ADAM17 siRNA showed a marked reduction in protein and mRNA expression. A decreased level of sAPP in the conditioned supernatant was found with ADAM10 but not ADAM17 knockdown. Densitometric analysis of APP and sAPP was shown at the right panel. (mean ± SD; n = 3). Statistical analysis was performed using student t -test. ***p < 0.001. All experiments were performed at least three times.
Anti Adam10, supplied by OriGene, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti adam10/product/OriGene
Average 88 stars, based on 1 article reviews
anti adam10 - by Bioz Stars, 2026-05
88/100 stars
  Buy from Supplier
rabbit igg polyclonal anti-human-adam10/madm antibody  (Biospes Inc)
90
Biospes Inc rabbit igg polyclonal anti-human-adam10/madm antibody
<t>ADAM10</t> and ADAM17 in APP processing of breast cancer cell lines. (A) Immunoblot analysis using antibodies against ADAM10 and ADAM17 showed the expression of both proteins in breast cancer cell lines (BT-549, MDA-MB231, MCF7, MDA-MB468, SK-BR-3 and ZR-75-1). β-actin was used as a control. Densitometric analysis of protein expression on the predominant form detected (pro-ADAM17 and mature ADAM10) from replicate experiments were shown at the lower panel. (mean ± SD; n = 3). (B) Knockdown of ADAM 10 but not ADAM17 showed reduced sAPP level in conditioned medium from cell line culture. Breast cancer cell line (MDA-MB231) was transfected with ADAM10 or ADAM17 siRNA showed a marked reduction in protein and mRNA expression. A decreased level of sAPP in the conditioned supernatant was found with ADAM10 but not ADAM17 knockdown. Densitometric analysis of APP and sAPP was shown at the right panel. (mean ± SD; n = 3). Statistical analysis was performed using student t -test. ***p < 0.001. All experiments were performed at least three times.
Rabbit Igg Polyclonal Anti Human Adam10/Madm Antibody, supplied by Biospes Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit igg polyclonal anti-human-adam10/madm antibody/product/Biospes Inc
Average 90 stars, based on 1 article reviews
rabbit igg polyclonal anti-human-adam10/madm antibody - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
rabbit polyclonal ab to the nh2 terminus of active adam-10 antibody  (Triple Point Biologics)
90
Triple Point Biologics rabbit polyclonal ab to the nh2 terminus of active adam-10 antibody
<t>ADAM10</t> and ADAM17 in APP processing of breast cancer cell lines. (A) Immunoblot analysis using antibodies against ADAM10 and ADAM17 showed the expression of both proteins in breast cancer cell lines (BT-549, MDA-MB231, MCF7, MDA-MB468, SK-BR-3 and ZR-75-1). β-actin was used as a control. Densitometric analysis of protein expression on the predominant form detected (pro-ADAM17 and mature ADAM10) from replicate experiments were shown at the lower panel. (mean ± SD; n = 3). (B) Knockdown of ADAM 10 but not ADAM17 showed reduced sAPP level in conditioned medium from cell line culture. Breast cancer cell line (MDA-MB231) was transfected with ADAM10 or ADAM17 siRNA showed a marked reduction in protein and mRNA expression. A decreased level of sAPP in the conditioned supernatant was found with ADAM10 but not ADAM17 knockdown. Densitometric analysis of APP and sAPP was shown at the right panel. (mean ± SD; n = 3). Statistical analysis was performed using student t -test. ***p < 0.001. All experiments were performed at least three times.
Rabbit Polyclonal Ab To The Nh2 Terminus Of Active Adam 10 Antibody, supplied by Triple Point Biologics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal ab to the nh2 terminus of active adam-10 antibody/product/Triple Point Biologics
Average 90 stars, based on 1 article reviews
rabbit polyclonal ab to the nh2 terminus of active adam-10 antibody - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
polyclonal antibodies anti-adam 10 n-terminal  (MD Biosciences)
90
MD Biosciences polyclonal antibodies anti-adam 10 n-terminal
<t>ADAM10</t> and ADAM17 in APP processing of breast cancer cell lines. (A) Immunoblot analysis using antibodies against ADAM10 and ADAM17 showed the expression of both proteins in breast cancer cell lines (BT-549, MDA-MB231, MCF7, MDA-MB468, SK-BR-3 and ZR-75-1). β-actin was used as a control. Densitometric analysis of protein expression on the predominant form detected (pro-ADAM17 and mature ADAM10) from replicate experiments were shown at the lower panel. (mean ± SD; n = 3). (B) Knockdown of ADAM 10 but not ADAM17 showed reduced sAPP level in conditioned medium from cell line culture. Breast cancer cell line (MDA-MB231) was transfected with ADAM10 or ADAM17 siRNA showed a marked reduction in protein and mRNA expression. A decreased level of sAPP in the conditioned supernatant was found with ADAM10 but not ADAM17 knockdown. Densitometric analysis of APP and sAPP was shown at the right panel. (mean ± SD; n = 3). Statistical analysis was performed using student t -test. ***p < 0.001. All experiments were performed at least three times.
Polyclonal Antibodies Anti Adam 10 N Terminal, supplied by MD Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal antibodies anti-adam 10 n-terminal/product/MD Biosciences
Average 90 stars, based on 1 article reviews
polyclonal antibodies anti-adam 10 n-terminal - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
adam10 rabbit polyclonal antibody  (OriGene)
90
OriGene adam10 rabbit polyclonal antibody
<t>ADAM10</t> and ADAM17 in APP processing of breast cancer cell lines. (A) Immunoblot analysis using antibodies against ADAM10 and ADAM17 showed the expression of both proteins in breast cancer cell lines (BT-549, MDA-MB231, MCF7, MDA-MB468, SK-BR-3 and ZR-75-1). β-actin was used as a control. Densitometric analysis of protein expression on the predominant form detected (pro-ADAM17 and mature ADAM10) from replicate experiments were shown at the lower panel. (mean ± SD; n = 3). (B) Knockdown of ADAM 10 but not ADAM17 showed reduced sAPP level in conditioned medium from cell line culture. Breast cancer cell line (MDA-MB231) was transfected with ADAM10 or ADAM17 siRNA showed a marked reduction in protein and mRNA expression. A decreased level of sAPP in the conditioned supernatant was found with ADAM10 but not ADAM17 knockdown. Densitometric analysis of APP and sAPP was shown at the right panel. (mean ± SD; n = 3). Statistical analysis was performed using student t -test. ***p < 0.001. All experiments were performed at least three times.
Adam10 Rabbit Polyclonal Antibody, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/adam10 rabbit polyclonal antibody/product/OriGene
Average 90 stars, based on 1 article reviews
adam10 rabbit polyclonal antibody - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
adam10  (OriGene)
90
OriGene adam10
<t>ADAM10</t> and ADAM17 in APP processing of breast cancer cell lines. (A) Immunoblot analysis using antibodies against ADAM10 and ADAM17 showed the expression of both proteins in breast cancer cell lines (BT-549, MDA-MB231, MCF7, MDA-MB468, SK-BR-3 and ZR-75-1). β-actin was used as a control. Densitometric analysis of protein expression on the predominant form detected (pro-ADAM17 and mature ADAM10) from replicate experiments were shown at the lower panel. (mean ± SD; n = 3). (B) Knockdown of ADAM 10 but not ADAM17 showed reduced sAPP level in conditioned medium from cell line culture. Breast cancer cell line (MDA-MB231) was transfected with ADAM10 or ADAM17 siRNA showed a marked reduction in protein and mRNA expression. A decreased level of sAPP in the conditioned supernatant was found with ADAM10 but not ADAM17 knockdown. Densitometric analysis of APP and sAPP was shown at the right panel. (mean ± SD; n = 3). Statistical analysis was performed using student t -test. ***p < 0.001. All experiments were performed at least three times.
Adam10, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/adam10/product/OriGene
Average 90 stars, based on 1 article reviews
adam10 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
adam10 polyclonal antibody, abby fluor 350 conjugated  (Bioss)
N/A
Cleaves the membrane-bound precursor of TNF-alpha at '76-Ala-|-Val-77' to its mature soluble form. Responsible for the proteolytical release of soluble JAM3 from endothelial cells surface. Responsible for the proteolytic release of several other cell-surface proteins,
   Buy from Supplier
adam10 polyclonal antibody, pe-cy3 conjugated  (Bioss)
N/A
Cleaves the membrane-bound precursor of TNF-alpha at '76-Ala-|-Val-77' to its mature soluble form. Responsible for the proteolytical release of soluble JAM3 from endothelial cells surface. Responsible for the proteolytic release of several other cell-surface proteins,
   Buy from Supplier
adam10 polyclonal antibody, biotin conjugated  (EpiGentek)
N/A
   Buy from Supplier

Image Search Results


ADAM10 and ADAM17 in APP processing of breast cancer cell lines. (A) Immunoblot analysis using antibodies against ADAM10 and ADAM17 showed the expression of both proteins in breast cancer cell lines (BT-549, MDA-MB231, MCF7, MDA-MB468, SK-BR-3 and ZR-75-1). β-actin was used as a control. Densitometric analysis of protein expression on the predominant form detected (pro-ADAM17 and mature ADAM10) from replicate experiments were shown at the lower panel. (mean ± SD; n = 3). (B) Knockdown of ADAM 10 but not ADAM17 showed reduced sAPP level in conditioned medium from cell line culture. Breast cancer cell line (MDA-MB231) was transfected with ADAM10 or ADAM17 siRNA showed a marked reduction in protein and mRNA expression. A decreased level of sAPP in the conditioned supernatant was found with ADAM10 but not ADAM17 knockdown. Densitometric analysis of APP and sAPP was shown at the right panel. (mean ± SD; n = 3). Statistical analysis was performed using student t -test. ***p < 0.001. All experiments were performed at least three times.

Journal: EBioMedicine

Article Title: Proteolytic cleavage of amyloid precursor protein by ADAM10 mediates proliferation and migration in breast cancer

doi: 10.1016/j.ebiom.2018.11.012

Figure Lengend Snippet: ADAM10 and ADAM17 in APP processing of breast cancer cell lines. (A) Immunoblot analysis using antibodies against ADAM10 and ADAM17 showed the expression of both proteins in breast cancer cell lines (BT-549, MDA-MB231, MCF7, MDA-MB468, SK-BR-3 and ZR-75-1). β-actin was used as a control. Densitometric analysis of protein expression on the predominant form detected (pro-ADAM17 and mature ADAM10) from replicate experiments were shown at the lower panel. (mean ± SD; n = 3). (B) Knockdown of ADAM 10 but not ADAM17 showed reduced sAPP level in conditioned medium from cell line culture. Breast cancer cell line (MDA-MB231) was transfected with ADAM10 or ADAM17 siRNA showed a marked reduction in protein and mRNA expression. A decreased level of sAPP in the conditioned supernatant was found with ADAM10 but not ADAM17 knockdown. Densitometric analysis of APP and sAPP was shown at the right panel. (mean ± SD; n = 3). Statistical analysis was performed using student t -test. ***p < 0.001. All experiments were performed at least three times.

Article Snippet: The primary antibodies used were as follows: anti-α-tubulin (DMIA; Sigma), anti-β-actin (C4, Santa Cruz); anti-APP N terminus (22C11; Millipore), anti-sAPPα (2B3, Immuno-Biological Laboratories), anti-sAPPβ (poly8134, Biolegend), anti-ADAM10 (polyclonal; Origene), anti-ADAM17 (H-300; Santa Cruz) and Ki67 (41,912; Ventana).

Techniques: Western Blot, Expressing, Transfection

Effect of ADAM10 knockdown in breast cancer partly reversed by sAPPα expression. (A) ADAM10 knockdown reduced proliferation in breast cancer cell line (MDA-MB231). MDA-MB231 was transfected with ADAM10 siRNA and were seeded (1 × 10 3 ) in a 96 well plate. Cell proliferation was measured at day 4 by CCK8 assay. (mean ± SD; n = 3). Statistical analysis was performed using student t-test. *p < 0.05. (B) ADAM10 knockdown reduced migration of breast cancer. Cells transfected ADAM10 siRNA (1 × 10 5 ) were seeded with 0.2 ml serum free medium in the upper chamber of Boyen chamber after overnight serum starvation. 0.5 ml medium supplemented with 10% FBS was added to the lower chamber. Migration was evaluated for 22 h. (C) ADAM10 knockdown effect can be reversed by sAPP overexpression. MDA-MB231 cells co-transfected with ADAM10 siRNA and sAPPα/full length (FL) construct were seeded (1 × 10 5 ) with 0.2 ml serum free medium in the upper chamber of Boyen chamber after overnight serum starvation. 0.5 ml medium supplemented with 10% FBS was added to the lower chamber. Migration was evaluated for 22 h. (mean ± SD; n = 3). Statistical analysis was performed using student t-test. ***p < 0.001; **p < 0.01; *p < 0.05; ns-no statistical significance. All experiments were performed at least three times.

Journal: EBioMedicine

Article Title: Proteolytic cleavage of amyloid precursor protein by ADAM10 mediates proliferation and migration in breast cancer

doi: 10.1016/j.ebiom.2018.11.012

Figure Lengend Snippet: Effect of ADAM10 knockdown in breast cancer partly reversed by sAPPα expression. (A) ADAM10 knockdown reduced proliferation in breast cancer cell line (MDA-MB231). MDA-MB231 was transfected with ADAM10 siRNA and were seeded (1 × 10 3 ) in a 96 well plate. Cell proliferation was measured at day 4 by CCK8 assay. (mean ± SD; n = 3). Statistical analysis was performed using student t-test. *p < 0.05. (B) ADAM10 knockdown reduced migration of breast cancer. Cells transfected ADAM10 siRNA (1 × 10 5 ) were seeded with 0.2 ml serum free medium in the upper chamber of Boyen chamber after overnight serum starvation. 0.5 ml medium supplemented with 10% FBS was added to the lower chamber. Migration was evaluated for 22 h. (C) ADAM10 knockdown effect can be reversed by sAPP overexpression. MDA-MB231 cells co-transfected with ADAM10 siRNA and sAPPα/full length (FL) construct were seeded (1 × 10 5 ) with 0.2 ml serum free medium in the upper chamber of Boyen chamber after overnight serum starvation. 0.5 ml medium supplemented with 10% FBS was added to the lower chamber. Migration was evaluated for 22 h. (mean ± SD; n = 3). Statistical analysis was performed using student t-test. ***p < 0.001; **p < 0.01; *p < 0.05; ns-no statistical significance. All experiments were performed at least three times.

Article Snippet: The primary antibodies used were as follows: anti-α-tubulin (DMIA; Sigma), anti-β-actin (C4, Santa Cruz); anti-APP N terminus (22C11; Millipore), anti-sAPPα (2B3, Immuno-Biological Laboratories), anti-sAPPβ (poly8134, Biolegend), anti-ADAM10 (polyclonal; Origene), anti-ADAM17 (H-300; Santa Cruz) and Ki67 (41,912; Ventana).

Techniques: Expressing, Transfection, CCK-8 Assay, Migration, Over Expression, Construct

Clinico-pathological association of ADAM10 expression in non-luminal breast cancers.

Journal: EBioMedicine

Article Title: Proteolytic cleavage of amyloid precursor protein by ADAM10 mediates proliferation and migration in breast cancer

doi: 10.1016/j.ebiom.2018.11.012

Figure Lengend Snippet: Clinico-pathological association of ADAM10 expression in non-luminal breast cancers.

Article Snippet: The primary antibodies used were as follows: anti-α-tubulin (DMIA; Sigma), anti-β-actin (C4, Santa Cruz); anti-APP N terminus (22C11; Millipore), anti-sAPPα (2B3, Immuno-Biological Laboratories), anti-sAPPβ (poly8134, Biolegend), anti-ADAM10 (polyclonal; Origene), anti-ADAM17 (H-300; Santa Cruz) and Ki67 (41,912; Ventana).

Techniques: Expressing

ADAM10 and APP co-expression associated with poor outcome in non-luminal breast cancers. Disease free survival and breast cancer specific survival of non-luminal breast cancer according to combined analysis of ADAM10 and APP expression by IHC using Kaplan-meier analysis. ADAM10 hi APP hi cases (purple line) showed the worst DFS and BCSS compared to ADAM10 lo APP lo cases (blue line), ADAM10 lo APP hi cases (green line) and ADAM10 hi APP lo cases (beige line).

Journal: EBioMedicine

Article Title: Proteolytic cleavage of amyloid precursor protein by ADAM10 mediates proliferation and migration in breast cancer

doi: 10.1016/j.ebiom.2018.11.012

Figure Lengend Snippet: ADAM10 and APP co-expression associated with poor outcome in non-luminal breast cancers. Disease free survival and breast cancer specific survival of non-luminal breast cancer according to combined analysis of ADAM10 and APP expression by IHC using Kaplan-meier analysis. ADAM10 hi APP hi cases (purple line) showed the worst DFS and BCSS compared to ADAM10 lo APP lo cases (blue line), ADAM10 lo APP hi cases (green line) and ADAM10 hi APP lo cases (beige line).

Article Snippet: The primary antibodies used were as follows: anti-α-tubulin (DMIA; Sigma), anti-β-actin (C4, Santa Cruz); anti-APP N terminus (22C11; Millipore), anti-sAPPα (2B3, Immuno-Biological Laboratories), anti-sAPPβ (poly8134, Biolegend), anti-ADAM10 (polyclonal; Origene), anti-ADAM17 (H-300; Santa Cruz) and Ki67 (41,912; Ventana).

Techniques: Expressing